Vraylar 1.5 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB25FH1N4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,845
Award facts
- Contract value 100% obligated
- $24,844.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $24,844.90 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Vraylar 1.5 mg capsules (30-count units). This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The contract involved no set-aside designation, reflecting open competition among qualified vendors. Performance will be completed by September 4, 2025, at AmerisourceBergen's corporate facility in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical supplier for federal military and veteran healthcare systems. The company's comprehensive DLA contract vehicle enables the supply of an extensive portfolio of pharmaceutical products—including specialty medications, brand-name and generic drugs, and medical supplies—to support Defense Health Agency operations and other federal healthcare programs globally. This delivery order for Vraylar, a neurological treatment medication, exemplifies the company's ongoing role in fulfilling federal pharmaceutical procurement requirements through the DLA Medical Supply Chain.
Quick answers
Who was awarded contract SPE2DB25FH1N4?
SPE2DB25FH1N4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FH1N4 worth?
The government has obligated $24,845 on SPE2DB25FH1N4.
Is contract SPE2DB25FH1N4 an order under another contract?
Yes. SPE2DB25FH1N4 is a delivery order under SPE2DB22D1103, an indefinite delivery contract.
Was contract SPE2DB25FH1N4 competed?
The extent of competition for SPE2DB25FH1N4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award